Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
GRCE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $44.18M
- EPS (TTM)
- -$1.17
- Dividend yield
- None
- 52-week range
- 1.79 – 5.18
- Day range
- 2.06 – 2.12
- Volume / Avg
- 84.23K / 172.27K
- Beta
- —
- Shares outstanding
- 21.04M
52-week range
GRCE stock today
Grace Therapeutics (GRCE) closed at $2.10 on Oct 7, up 1.69% (+$0.035), versus the S&P 500's 0.22% decline. Trading was light, with 84.23K shares changing hands, about 49% of the average daily volume. Shares are 59.5% below their 52-week high of $5.18, set on Apr 2, 2026 and 17.3% above the 52-week low of $1.79, near the bottom of the past year's range.
GRCE is down 39.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 30.5%. Grace Therapeutics has posted a net loss over the last twelve months (EPS of -$1.17), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Grace Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Princeton, NJ
Grace Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NSRXNasus Pharma Ltd. | 3.78 | -1.69% | $44.22M | vs GRCE |
| HOWLWerewolf Therapeutics Inc. | 0.9201 | -0.01% | $44.72M | vs GRCE |
| VERUVeru Inc. | 2.46 | -0.40% | $41.94M | vs GRCE |
| IXHLIncannex Healthcare Inc. | 3.18 | +1.27% | $39.89M | vs GRCE |
| FLNAFilana Therapeutics Inc. | 0.8157 | -6.77% | $39.40M | vs GRCE |
| SCYXSCYNEXIS Inc. | 4.78 | -1.24% | $47.56M | vs GRCE |
| CELUCelularity Inc. Class A | 1.47 | -6.96% | $47.70M | vs GRCE |
| CRVOCervoMed Inc. | 3.18 | -4.79% | $48.08M | vs GRCE |
Indexes, lists and sector
Grace Therapeutics stock FAQ
What is Grace Therapeutics's stock price today?
GRCE last traded at $2.10 as of Oct 7, 4:00 PM EDT, up 1.69% on the day. Prices are delayed at least 15 minutes.
Does Grace Therapeutics pay a dividend?
No. Grace Therapeutics does not currently pay a regular cash dividend.
Has GRCE ever split its stock?
Yes. The most recent GRCE stock split was a 1-for-6 split on Jul 10, 2023, one of 3 splits on record.
What is the GRCE 52-week high?
The 52-week high for GRCE is $5.18 and the 52-week low is $1.79. The stock is currently 59.5% below its high.